Voriconazole inhalation (Zambon)

伏立康唑吸入剂 (Zambon)

Report date: 2026/03/26 20:00:17

Base Information

Drug NameVoriconazole inhalation (Zambon)
Drug Alias NameZP-059
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsAspergillosis, Allergic Bronchopulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZambon Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZambon Spa
Active IndicationsN/A
Inactive IndicationsAspergillosis, Allergic Bronchopulmonary

Other Information

ATC CodeN/A
Related LinksN/A